AN2 Therapeutics, Inc. Common Stock (ANTX)

Typically moves ±9.39% on earnings
EARNINGS ANALYTICS
search

AN2 Therapeutics, Inc. Common Stock (ANTX) has a 15-report earnings history dating back to May 10, 2022. Its average absolute post-earnings move is ±9.39%, and 46.7% of those reactions were positive. Its largest post-earnings gain was +64.54% (Aug 11, 2022) and its largest decline was -9.32% (May 11, 2026).

Earnings reactions

How ANTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

15

Avg Abs. Movement

±9.39%

Positive %

46.7%

Negative %

53.3%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 11, 2026 ☽ POST -9.32% open_in_new
Mar 17, 2026 ☽ POST -7.69% open_in_new
Nov 12, 2025 ☽ POST +0% open_in_new
Mar 25, 2025 ☽ POST +3.68% open_in_new
event

Earnings Count

15

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.39%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 9 →
9
Funds holding
$7056170
Total value held
Buying
6 added · 1 reduced
Bank Of Nova Scotia
$1570443 NEW BUY
Bank Of America Corp /De/
$1346461 +2.18%
Blackrock, Inc.
$1090187 -1.41%
Bank Of Montreal /Can/
$889634 NEW BUY
Pfizer Inc
$815436 Held

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
4 20260710 open_in_new SEC.gov
4 20260710 open_in_new SEC.gov
4 20260710 open_in_new SEC.gov
4 20260710 open_in_new SEC.gov
8-K 20260609 open_in_new SEC.gov
8-K 20260604 open_in_new SEC.gov
4 20260602 open_in_new SEC.gov
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
CORRESP 20260416 open_in_new SEC.gov
UPLOAD 20260415 open_in_new SEC.gov

Frequently asked about ANTX earnings

How much does ANTX stock move after earnings? expand_more

Over 15 reports, ANTX has moved an average of ±9.39% the session after earnings, closing higher 46.7% of the time.

What was ANTX's biggest post-earnings move? expand_more

ANTX's largest post-earnings gain on record was +64.54% on Aug 11, 2022, and its largest decline was -9.32% on May 11, 2026.

Where can I find AN2 Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of AN2 Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers